健康

Search documents
“链”式赋能守护全民健康——在链博会触摸大健康产业创新脉搏
Xin Hua She· 2025-07-17 11:35
用一台小小的设备完成身体不同部位的超声检查、将人工智能运用于骨科手术中、以数字化手段助力健 康生活管理……走进正在举行的第三届中国国际供应链促进博览会健康生活链展馆,几乎每一个展区都 像是微缩的创新实验室,不仅展现从出生到养老的全生命周期健康产业链条,更让观众直观体验最前沿 科技成果,感受到"让生命更加精彩"的美好愿望正化为触手可及的现实。 占地面积约1.2万平米的健康生活链展馆内,吸引了100余家企业参展。在华大集团展台,记者看到一名 工作人员正用一款不到300克的智能掌上超声设备给一名参观者现场体验甲状腺超声检查。 据介绍,这款设备可完成人体浅表组织、外周血管及腹部器官等多项检查,通过一键切换探头模式快速 适应不同检查需求。其适用场景广泛,既可用于医疗机构快速评估患者病情,辅助医生制定治疗方案; 也可作为家庭医生"助手",方便上门随访时监测患者健康状况;同时凭借小巧便携、操作简便的特点, 还能广泛应用于基层医疗筛查工作。 华 大集团展台工作人员正在给一名参观者现场体验甲状腺超声检查。新华社记者李恒 摄 生物制药公司诺和诺德从"链接全球创新""链启慢病管理""共筑健康中国"等方面集中展示了其植根中国 30余 ...
华润医药(03320.HK)订立有限合伙协议
Ge Long Hui· 2025-07-17 10:55
Group 1 - China Resources Pharmaceutical (03320.HK) announced the establishment of a joint venture fund named China Resources Pharmaceutical (Chengdu) Innovation Investment Fund Partnership (Limited Partnership) with a proposed scale of RMB 1 billion and a total duration of seven years [1] - The group's proposed capital contribution will be approximately RMB 245 million, accounting for about 24.5% of the total fund capital [1] - The fund is expected to primarily engage in equity investment, venture capital, and investment management activities, focusing on the pharmaceutical and health industry as well as strategic emerging sectors [1] Group 2 - The fund will target investments in areas such as chemical innovative drugs, biological drugs (including vaccines), high-end medical devices (including IVD), traditional Chinese medicine supplements, and synthetic biology, among other strategic emerging fields [1] - The company believes it can leverage the fund's professional investment team resources to effectively control risks associated with mergers and acquisitions and innovation projects, ensuring the quality of target companies and accelerating strategic mergers and acquisitions in the pharmaceutical industry [2] - This strategy aims to enhance the company's long-term sustainable development capabilities within the pharmaceutical sector [2]
经济越来越差,这八大行业越赚爆!
创业家· 2025-07-17 10:10
Core Insights - The article discusses how certain industries are thriving despite the prevailing narrative of economic hardship, highlighting eight sectors that present significant business opportunities in a low-desire society [3][4]. Group 1: Key Industries - The second-hand economy is booming, with companies like Dabaiku in Japan and Hongbulin in China seeing substantial revenue growth as consumers turn to second-hand luxury goods [8][6]. - The pet economy is flourishing, with brands like Inaba and Guobao experiencing strong stock performance, as consumers prioritize spending on pet products over traditional family expenses [9][10]. - The adult care market, exemplified by Unicharm's success in Japan, is projected to grow significantly in China, driven by an aging population [14][16]. - Health food and beverage sectors are expanding, with brands like Dongfang Shuye and Jianchun capitalizing on the rising health consciousness among consumers [19][20]. - The beauty economy remains robust, with products like collagen supplements and home beauty devices achieving high sales, indicating a persistent demand for beauty solutions [23]. - Outdoor and leisure products are gaining traction, with brands like Snow Peak and Kailas seeing increased sales as consumers seek outdoor experiences [25]. - The emotional economy is on the rise, with brands like Labubu and Rio catering to consumers' desires for comfort and enjoyment [27][28]. - The convenience economy is thriving, with frozen food brands and smart home appliances addressing the needs of younger generations who prioritize time-saving solutions [32][33]. Group 2: Market Trends - The article emphasizes that even in a low-desire period, there are significant opportunities for companies that can identify and invest in counter-cyclical sectors [36]. - The upcoming seminar aims to provide insights into the methodologies of successful consumer giants in Japan and China, focusing on efficiency, demand reconstruction, and capital strategies [37].
以岭健康携怡梦、津力旺等健康产品亮相链博会
Sou Hu Wang· 2025-07-17 07:29
Core Viewpoint - The third China International Supply Chain Promotion Expo (Chain Expo) was held from July 16 to 20 in Beijing, focusing on the theme "Linking the World, Creating the Future" and showcasing various sectors including advanced manufacturing, clean energy, smart vehicles, digital technology, health living, and green agriculture, attracting 651 companies and organizations from 75 countries and regions [1][10] Company Overview - Yiling Health participated in the Chain Expo, showcasing innovative health products in the "Health Living Chain" exhibition area, demonstrating its development cluster from medicine to health [1][3] Health Industry Focus - The "Health Living Chain" exhibition area emphasizes key products and technologies in the health sector, promoting a green and healthy lifestyle while supporting consumption and domestic demand [3] - Yiling Health's strategy aligns with this focus, integrating traditional medicine and health practices to create a comprehensive health management solution covering all life stages [3][4] Product Innovation - Yiling Health has developed a diverse range of health products to address common health issues such as high blood sugar, abnormal blood lipids, and sleep disorders, reflecting a shift from treatment-centered to health management-centered approaches [4][6] - Key products showcased include: - **Yimeng Beverage**: Targets blood lipid levels and sleep quality using a blend of five medicinal ingredients [4] - **Jinliwang Beverage**: A sugar-free drink designed for blood sugar management, utilizing six medicinal ingredients [6] - **Wanbi'an Soft Capsules**: Aimed at improving sleep quality, featuring the traditional calming herb sour jujube seed [6] Comprehensive Health Solutions - Yiling Health's product matrix extends beyond blood sugar and lipid management to include hypertension, weight loss, anti-aging, immune enhancement, fatigue resistance, and bone health, promoting proactive health management [7] - The company emphasizes the importance of managing health risks early to prevent chronic diseases, advocating for a philosophy of "health needs management" [7] Quality Assurance in Production - Yiling Health ensures product quality through strict control of traditional Chinese medicine materials, establishing a collaborative model with local farmers to guarantee the authenticity and quality of raw materials [8] - The company has built over 60 high-standard medicinal herb cultivation bases across major regions in China, covering more than 40 varieties of traditional Chinese medicine [8][9] Future Outlook - Yiling Health aims to leverage the Chain Expo to deepen exchanges and share its experiences in building a full lifecycle service industry chain in traditional Chinese medicine, exploring new paths and models for health industry development [10]
【2025链博会】鲁商福瑞达:以中药科技+合成生物重构韧性供应链
Huan Qiu Wang· 2025-07-17 06:42
【环球网科技报道 记者 林迪】7月16日,第三届中国国际供应链促进博览会(链博会)正式开幕,鲁商集团旗下福瑞达携"中药绿色智造+合成生物"双擎成 果亮相,集中展示从中药提取、合成生物原料到终端护肤品、口服健康品的全链条创新。 另一款MatrixColla-1 愈胶原则采用Ⅲ型重组胶原、弹性蛋白、纤连蛋白精准配比,模拟真皮层细胞外基质结构,实现"由内而外"全维度抗衰。 绿色供应链:可降解包装缩短降解周期 60% 绿色可持续贯穿全链。福瑞达出口原料矩阵——二羟基苯乙醇、透明质酸钠Hyaskin®、hyaoligo®、依克多因等皆通过欧盟ECOCERT认证,生物发酵工艺较 传统化学法减排35%。现场放置的透明箱对比展示:传统PE瓶需450年降解,而珂谧系列植物基包装仅需180天即可完全分解,且密封性、跌落测试均优于行 业标准。 记者来到展区现场,明颜舒萃、MatrixColla-1 愈胶原、珂谧穿膜胶原棒等明星产品前排起体验长队,一株积雪草到一支抗衰精华的"绿色旅程"被完整还原, 直观呈现中国美妆与健康产业的科技跃迁。 "我们要打造的不是'单点闪光',而是'全域创新'的科创生态。"鲁商集团相关负责人表示,福瑞达此次 ...
北京市“推动AI赋能高端科学仪器创新”三年行动计划出炉
仪器信息网· 2025-07-17 04:42
Core Viewpoint - The article discusses the "Action Plan" aimed at accelerating the integration of artificial intelligence (AI) into scientific research in Beijing, with a focus on developing high-quality scientific instruments and fostering innovation in various fields [2][4][7]. Group 1: Development Goals - By 2027, the plan aims to leverage Beijing's AI innovation advantages to establish new pathways for scientific research, focusing on foundational scientific issues and enhancing the application of AI across multiple fields [8]. - The initiative includes the construction of at least 10 high-quality scientific databases to support AI applications in various research areas, targeting over 10 million users [8]. Group 2: Key Tasks - The plan emphasizes critical technology breakthroughs, including foundational theoretical research in AI, the development of a universal scientific foundational model, and new generation scientific computing simulation software [9][10][11]. - Infrastructure development is a priority, with goals to create an open scientific data platform and a collaborative computing power platform to enhance research efficiency [12][13]. Group 3: Application Acceleration - The plan promotes the use of AI in basic scientific research, medical health innovation, and new materials development, aiming to enhance research efficiency and discovery processes [15][16][17]. - Specific focus is placed on empowering high-end scientific instruments through AI, encouraging collaboration between universities, research institutions, and enterprises to develop advanced scientific equipment [18]. Group 4: Innovation Ecosystem - The initiative aims to build a public service innovation platform for scientific intelligence, attract and cultivate innovative talent, and establish a multi-channel investment and financing service system [20][21][22]. - It also seeks to create a competitive scientific intelligence industry cluster and promote international cooperation and open-source ecosystems [23][24][25].
315家杭州上市“预备军”名单公布
Hang Zhou Ri Bao· 2025-07-17 03:09
Group 1 - The latest list of key companies planned for listing in Hangzhou includes 315 firms across various sectors such as biomedicine, digital economy, high-end manufacturing, and modern services [1][2] - Notable companies on the list include traditional brands like Hu Qing Yu Tang and Zhejiang Salt Industry Co., as well as industry leaders like Zhejiang Long Aviation and Hikvision Robotics [1][2] - Emerging tech companies from the "Hangzhou Six Little Dragons," such as Qunhe Information and Yunsenshu Technology, are also included in the updated list [1][2] Group 2 - The technology and medical sectors are highlighted as two major areas with a significant number of promising companies, including Qunhe Information Technology and WeDoctor, a digital health unicorn [2] - Hu Qing Yu Tang, a century-old brand, and several other medical firms like Nucleon Health and Sugarji Medical are also part of the growing biomedical landscape in Hangzhou [2] Group 3 - The Hangzhou government has been actively promoting the capital market, launching initiatives like the "Phoenix Action Plan" to support strategic emerging industries [3] - By mid-2024, the Hangzhou Innovation Fund and other related funds had approved a total fund size of 170.6 billion yuan, investing in 1,580 projects and 2,600 companies, with over 90% of the funding directed towards private enterprises [3] Group 4 - As of July 15, there are 234 listed companies in Hangzhou, with 20 companies having a market capitalization exceeding 30 billion yuan [4] - The Binjiang District is home to the highest number of listed companies, accounting for 19.7% of the total, while other districts like Xihu and Yuhang also contribute significantly [4] - Four Hangzhou companies, including Zhongce Rubber and Xinkai Technology, successfully went public on the A-share market this year, with Zhongce Rubber achieving a market value close to 50 billion yuan shortly after its IPO [4] Group 5 - The Hong Kong capital market is increasingly attracting Hangzhou companies, with 63 firms listed as of July 15 [6] - Recent listings include Saint Bella, which became the first global family quality care stock, and TIDE Pharmaceutical, which debuted on the Hong Kong Stock Exchange [6] - Several other Hangzhou companies are in the process of applying for listings on the Hong Kong Stock Exchange, indicating a growing trend of companies seeking opportunities in this market [6]
6月中国一级市场发生融资事件716个,环比增长13%;IPO井喷,26家企业上市;AI赛道狂飙丨投融资月报
创业邦· 2025-07-16 23:55
以下文章来源于睿兽Pro ,作者Bestla 睿兽Pro . 创业邦旗下横跨一二级市场的科创数据平台。实时投资数据、追踪产业创新。找数据、做分析、链资 源,就上睿兽分析。 2025年6月观察&综述 睿兽分析 数据显示, 2025年06月中国一级市场发生融资事件 716 个 ,比上月增加 84 个 ( 13%) ,比去年同期增加 27 个 ( 4%) 。已披露融资总额 332.74亿 元人民币,比上月增加 135.03亿 元人民币 ( 68%) ,比去年同期减少 60.15亿 元人民币 ( 15%) 。 2025年06月, 热门融资行业 主要为: 智能制造(179个)、人工智能(120个)、医疗健康(68 个) ,其中人工智能行业较上月上升较多 ( 48%) 。 一级市场热门地区主要为: 广东(133个)、江苏(116个)、北京(94个)、上海(93个)、浙 江(83个) 。 阶段分布上:早期(555个)、成长期(135个)、后期(26个)。 2025年06月, 全球大额融资事件新增44个 ,其中中国新增9个。全球独角兽企业新增10家,其中 中国新增1家。 2025年06月, 投资活跃的机构 主要为: 顺禧基金 ...
Stock Of The Day: Is It Time To Buy Humana?
Benzinga· 2025-07-16 18:41
Humana Inc. HUM is consolidating on Wednesday. But it may be about to reverse and rally.It is oversold and getting close to a support level, and these are bullish dynamics that could set the stage for a move higher. This is why it is the Stock of the Day.Many trading strategies and styles are based on the concept of reversion to the mean. If a stock gets overextended in one direction, there is a good chance it reverses and heads back in the other direction.Most of the time, a stock stays within its typical ...
Why Cigna (CI) is a Top Dividend Stock for Your Portfolio
ZACKS· 2025-07-16 16:45
Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But for income investors, generating consistent cash flow from each of your liquid investments is your primary focus.While cash flow can come from bond interest or interest from other types of investments, income investors hone in on dividends. A dividend is the distribution of a company's earnings paid out to shareholders; it's often viewed by its dividend yield, a metric th ...